Clinical characteristics and natural history of patients with low-grade reflux esophagitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 9, 2002, Pages 949-954

  Manabe, Noriaki ^a   Yoshihara, Masaharu ^a   Sasaki, Atsunori ^a   Tanaka, Shinji ^a   Haruma, Ken ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Esophageal motility; Helicobacter pylori; Natural history; Reflux esophagitis

Indexed keywords

ADULT; AGE; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RECURRENT DISEASE; REFLUX ESOPHAGITIS; RISK FACTOR; SEX; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036379773     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02783.x     Document Type: Article

References (29)

1. Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993; 3 (Suppl.): 3-10.
2. Howard PJ, Heading RC. Epidemiology of gastro-esophageal reflux disease. World J. Surg. 1992; 16: 288-93.
3. Lau GK, Hui WM, Lau CP, Hu WH, Lai KC, Lam SK. Abnormal gastro-oesophageal reflux in Chinese with atypical chest pain. J. Gastroenterol. Hepatol. 1996; 11: 775-9.
4. Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig. Dis. Sci. 1997; 42: 702-6.
5. Manabe N, Haruma K, Mihara M et al. The increasing incidence of reflux esophagitis during the past 20 years in Japan (Abstract). Gastroenterology 1999; 166: A244.
6. Palmer ED. The hiatus hernia-oesophagitis-esophageal stricture complex. Am. J. Med. 1968; 44: 566-79.
7. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gatroenterology 1996; 111: 85-92.
8. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-64.
9. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand. J. Gastroenterol. 1999; 231 (Suppl.): 48-54.
10. Armstrong D, Pare P, Pericak D, Pyzyk M. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am. J. Gastroenterol. 2001; 96: 2849-57.
11. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
12. Brunnen PL, Karomody AM, Needham CD. Severe peptic esophagitis. Gut 1969; 10: 831-7.
13. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51: 24-9.
14. Kuster E, Ros E, Toledo-Pimentel V et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow-up of 107 patients. Gut 1994; 34: 8-14.
15. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease. 17-22 year follow-up of 60 patients. Am. J. Gastroenterol. 1997; 92: 37-41.
16. Bardhan KD. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy-a sideways glance. Yale J. Biol. Med. 1996; 69: 211-24.
17. Mihara M, Haruma K, Kamada T et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: Evaluation in a country with high prevalence of atrophic gastritis.Helicobacter 1999; 4: 40-8.
18. Fass R, Sampliner RE, Mackel C, McGee D, Rappaport W. Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects. Dig. Dis. Sci. 1993; 38: 1926-8.
19. Ter RB, Johnston BT, Castell DO. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis. Esophagus 1998; 11: 106-8.
20. Koelz HR, Birchler R, Bretholz A et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198-205.
21. Hetzel DJ, Dent J, Reed WD et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1998; 95: 903-12.
22. Havelund T, Laursen LS, Skoubo-Kristensen E et al. Omeprazole and ranitidine in treatment of reflux esophagitis: double blind comparative trial. Br. Med. J. 1988; 296: 89-92.
23. Dent J, Yeomans ND, Mackinnon M et al. Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994; 35: 590-8.
24. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up, its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-6.
25. Schindlbeck NE, Klauser AG, Berghammer G, Londong W, MullerLissner SA. Three year follow-up of patients with gastroesophageal reflux disease. Gut 1992; 33: 1016-19.
26. Tytgat GNJ, Anker Hansen OJ, Carling L, Geldof H, Glise H. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand. J. Gastroenterol. 1992; 27: 175-83.
27. Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ. Concentration of refluxed acid and esophageal mucosal injury. Am. J. Surg. 1992; 164: 522-6.
28. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on oesophageal volume clearance. Gastroenterology 1988; 94: 73-80.
29. Hewson EG, Ott DJ, Dalton CB, Chen YM, Wu WC, Richiter JE. Manometry and radiology (Complementary studies in the assessment of esophageal motility disorders). Gastroenterology 1990; 98: 626-32.